PictorLabs, a Los Angeles, CA-based digital pathology company, raised $15.2M in funding.
The round was led by M Ventures, SCC Soft Computer, and Koç Holding.
The company intends to use the funds to expand its biomarker portfolio, develop novel products, grow its talent base, and build out its corporate infrastructure.
Founded by Aydogan Ozcan and Yair Rivenson, PictorLabs is a digital pathology company providing AI virtual staining technology to innovate histopathology and accelerate clinical research with the goal of improving patient outcomes. The company’s technology applies deep learning algorithms to efficiently and accurately stain tissues in silico, producing near-instantaneous virtual stains. From a single unstained tissue sample, its proprietary platform can produce an unlimited number of virtual stains that are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and is creating specialized virtual biomarker stains for indications in which there is a large demand for novel and accelerated diagnostic tests.
Recently, PictorLabs established a partnership with Charles River Laboratories as part of their sustainability initiatives to reduce water consumption and chemical waste through the adoption of virtual staining technology.
Since its founding in 2019, the company has raised $18.8M.
FinSMEs
05/12/2022